shortagewatch

Home / Nervous system / Lidocaine

ATC N01BB02 · Anesthetics

Lidocaine shortage

As of 31 Oct 2026, Lidocaine has a reported shortage in 3 of the 5 countries we track (Italy, Spain, Austria), covering 7 products.

Countries3/5
Products7packs or presentations
Short since11 Apr 202519 months ago
Earliest return9 Dec 2026company estimate
No return date5products
Main reasonCommercial decision or withdrawal

Timeline

ItalySpainAustria
20262027LIDOCAINA CLORIDRATO FISIOPHARMALIDOCAINA CLORIDRATO FISIOPHARMATRUVINUTTRUVINUTLIDOCAINA KABILIDOCAINA KABILIDOFASTLIDOFASTLIDOFASTLIDOFASTXILONIBSA 10 mg/pulsación, solución para pulXILONIBSA 10 mg/pulsación, solución para pulverización cutánea, 1 frasco de 50 mlXylocain 2 % - Gel, 1 StückXylocain 2 % - Gel, 1 Stücktoday

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Affected products

CountryProductHolderSinceExpected backReason
ITLIDOCAINA CLORIDRATO FISIOPHARMAFISIOPHARMA S.R.L.11 Apr 2025not givenCommercial decision or withdrawal
Motivi commerciali: forniture discontinue
ITTRUVINUTGRUNENTHAL ITALIA S.R.L.15 Jun 2025not givenCommercial decision or withdrawal
Sospensione commercializzazione
ITLIDOCAINA KABIFRESENIUS KABI ITALIA S.R.L.5 Aug 2025not givenManufacturing problem
Problemi produttivi
ITLIDOFASTAZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A.3 Nov 2025not givenCommercial decision or withdrawal
Motivi commerciali (carenza relativa solo al canale retail)
ITLIDOFASTAZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A.31 Jan 2026not givenCommercial decision or withdrawal
Motivi commerciali (carenza relativa solo al canale retail)
ESXILONIBSA 10 mg/pulsación, solución para pulverización cutánea, 1 frasco de 50 mlLaboratorios Inibsa S.A.27 Oct 20269 Dec 2026Not stated
ATXylocain 2 % - Gel, 1 Stück limitedAspen Pharma Trading Limited23 Apr 202631 Jan 2027Manufacturing problem
Kapazitätsengpässe bei der Herstellung

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Related medicines also in short supply